Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04030377 · ClinicalTrials.gov registry record

Postop Catheterization for Urinary Retention

A clinical trial, sponsored by Endeavor Health.

Terminated
Registry status
47
Enrollment target

NCT04030377: Clinical Trial study, sponsored by Endeavor Health.

NCT04030377 is a clinical trial that was terminated before completion, run by Endeavor Health. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04030377 was terminated before completion, sponsored by Endeavor Health.

TERMINATED
Registry status
47 participants
Enrollment target

Study Summary

This study investigates patient's preference and satisfaction with choice of catheterization after surgical urogynecological procedures.

Primary Outcome

Assessed through post-operative questionnaire completion

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2010-04
Est. Completion 2015-02-20
Endeavor Health

94 total trials

Why NCT04030377 stopped before completion

NCT04030377 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT04030377 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04030377 about?

NCT04030377 is a clinical study titled "Postop Catheterization for Urinary Retention". This study investigates patient's preference and satisfaction with choice of catheterization after surgical urogynecological procedures.

What is the current status of trial NCT04030377?

This trial is currently terminated. The enrollment target is 47 participants. The study started on 2010-04. Estimated completion is 2015-02-20.

Who is sponsoring clinical trial NCT04030377?

This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT04030377, the US trial registry maintained by the National Library of Medicine. NCT04030377 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.